» Articles » PMID: 15843111

What's Community Got to Do with It? Implementation Models of Syringe Exchange Programs

Overview
Journal AIDS Educ Prev
Date 2005 Apr 22
PMID 15843111
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Syringe exchange programs (SEPs) have been shown to be highly effective in reducing HIV transmission among injection drug users (IDUs). Despite this evidence, SEPs have not been implemented in many communities experiencing HIV epidemics among IDUs. We interviewed 17 key informants in nine U.S. cities to identify factors and conditions that facilitated or deterred the adoption of SEPs. Cities were selected to represent diversity in size, geographic location, AIDS incidence rates, and SEP implementation. Key informants included HIV prevention providers, political leaders, community activists, substance use and AIDS researchers, and health department directors. SEPs were established by one or more of three types of implementation models: (a) broad community coalition support, (b) community activist initiative, and (c) top-down decision making by government authorities. In each model, coalition building and community consultation were critical steps for the acceptance and sustainability of SEPs. When others were not prepared to act, community activists spearheaded SEP development, taking risks in the face of opposition, but often lacked the resources to sustain their efforts. Leadership from politicians and public health officials provided needed authority, clout, and access to resources. Researchers and scientific findings lent force and legitimacy to the effort. Rather than adopting adversarial positions, successful SEP implementers worked with or avoided the opposition. Fear of repercussions and lack of leadership were the greatest barriers to implementing SEPs. Communities that successfully implemented SEPs were those with activists willing to push the agenda, public officials willing to exercise leadership, researchers able to present authoritative findings, and proponents who effectively mobilized resources and worked to build community coalitions, using persistent but nonadversarial advocacy.

Citing Articles

Racialized environments and syringe services program implementation: County-level factors.

Bluthenthal R, Humphrey J, Strack C, Wenger L, LaKosky P, Patel S Drug Alcohol Depend. 2024; 263:112430.

PMID: 39216198 PMC: 11409812. DOI: 10.1016/j.drugalcdep.2024.112430.


"Make yourself un-NIMBY-able": stakeholder perspectives on strategies to mobilize public and political support for overdose prevention centers in the United States of America.

Rosen J, Thompson E, Tardif J, Collins A, Marshall B, Park J Harm Reduct J. 2024; 21(1):40.

PMID: 38355641 PMC: 10868085. DOI: 10.1186/s12954-024-00955-6.


An Early Implementation Analysis of Syringe Services Programs in Kentucky: Barriers and Facilitators Identified by Program Operators and Local Officials.

Harris S AIDS Behav. 2022; 27(4):1248-1258.

PMID: 36318428 DOI: 10.1007/s10461-022-03861-9.


Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs.

Resiak D, Mpofu E, Rothwell R Healthcare (Basel). 2022; 10(5).

PMID: 35627918 PMC: 9141102. DOI: 10.3390/healthcare10050781.


Predictors of US states' adoption of naloxone access laws, 2001-2017.

Bohler R, Hodgkin D, Kreiner P, Green T Drug Alcohol Depend. 2021; 225:108772.

PMID: 34052687 PMC: 8282714. DOI: 10.1016/j.drugalcdep.2021.108772.


References
1.
Watters J, Estilo M, Clark G, Lorvick J . Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994; 271(2):115-20. View

2.
. Interventions to prevent HIV risk behaviors. NIH Consens Statement. 1997; 15(2):1-41. View

3.
Des Jarlais D, Friedman S . Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Rep. 1998; 113 Suppl 1:182-8. PMC: 1307740. View

4.
Paone D, Des Jarlais D, Clark J, Shi Q . Syringe-exchange programs in the United States: where are we now?. AIDS Public Policy J. 1996; 11(3):144-7. View